This 973-page report contains 153 tables and provides comprehensive analysis of the diagnostic testing markets outside the main hospital laboratory (ERs, ORs, and ICUs). The report includes analysis of the market dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging opportunities for instrument and consumable suppliers. We trust, this report will help diagnostic products suppliers develop more effective business, R&D and marketing strategies.
The growing economic pressures on hospitals, coupled with advances in diagnostic technologies, intensifying competition among suppliers and physicians, and changing consumer demands are shifting diagnostic testing from hospitals closer to the patient.
Market Segmentation Analysis
- Review of the ER, OR and ICU market segments, including their dynamics, trends,
structure, size, growth and major suppliers.
- Five-year test volume and sales forecasts for chemistry, immunodiagnostic, microbiology,
hematology and coagulation procedures by market segment:
- Emergency Rooms
- Operating/Recovery Suites
and test category:
- Routine and Special Chemistry
- Microbiology/Infectious Diseases
- Flow Cytometry
- Drugs of Abuse
- Endocrine Function
- Tumor Markers
Sales and Market Share Analysis
- Sales and market shares of major reagent and instrument suppliers.
Current and Emerging Products
- Analysis of over 130 diagnostic procedures.
- Review of leading POC chemistry, immunoassay, hematology and coagulation analyzers,
both currently marketed and those in development, including their operating characteristics,
features and selling prices.
- Emerging technologies and their applications for POC testing.
- Comprehensive listings of companies developing or marketing POC diagnostic technologies
and products, by test.
- Assessments of major suppliers and emerging market entrants, including their sales,
product portfolios, marketing tactics, joint ventures, and new products in R&D.
- Specific opportunities for new POC instruments and reagent systems with potentially
significant market appeal during the next ten years.
- Design criteria for POC testing products.
- Alternative business expansion strategies.
- Potential market entry barriers and risks.
This report is based on a combination of primary and secondary sources of information, including review of recent technical and business publications, manufacturer product literature, industry analyst reports, and VPGMarketResearch's proprietary data files.
Contains 973 pages and 153 tables
SIMILAR MARKET STUDIES
France Immunodiagnostics Market 2017-2021: Opportunities for Instrument and Reagent Suppliers, Market Segment Forecasts and Shares, Competitive Strategies, Emerging Technologies, Instrumentation Review
VPGMarketResearch.com's new report is a strategic analysis of major business opportunities emerging in the French clinical chemistry and immunodiagnostic markets during the next five years. The report explores future trends in the French market; provides estimates of the specimen, test and sales volumes, as well as major suppliers’ sales and ...
December 2016 | $0 | View Details >>
This new 247-page report from VPGMarketResearch.com provides a comprehensive analysis of the Japanese therapeutic drug monitoring market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers.
April 2015 | $1700 | View Details >>
2016 Europe Automated Microbiology Market: Supplier Shares, Country Forecasts, Innovative Technologies, Instrumentation Review, Competitive Strategies-Molecular Diagnostics, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, Immunodiagnostics
Complete report $19,850. DataPack (test volumes, sales forecasts, supplier shares) $12,900. VPGMarketResearch.com's new report is a five-country strategic analysis of major business opportunities emerging in the automated microbiology market during the next five years. The report examines key trends in the major European countries (France, Germany, Italy, Spain, UK); reviews current and ...
November 2015 | $12900 | View Details >>
The report presents a detailed analysis of the Hepatitis diagnostics market in Italy. Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed. The report provides five-year test volume and sales forecasts for HAV NAT, HBV NAT, HBs Ag, HCV, HCV NAT, Anti-HBc, Anti-HBs, Anti-HAV, Hepatitis Delta, HBc Ag, HBe Ag, and ALT/SGPT tests performed in the following markets:
November 1999 | $0 | View Details >>
UPCOMING MARKET RESEARCH REPORTS
2017 © Copyright Big Market Research